Heather Prichard, Ph.D. is Humacyte’s Chief Operating Officer, with overall responsibility for translating the company’s innovative mission, vision and strategies into actionable activities. Dr. Prichard provides leadership and oversight to the commercial manufacturing and product development organizations, including vascular research and development, process development, analytical and quality control testing, manufacturing and supply chain management.

Prior to Dr. Prichard’s appointment as Chief Operating Officer in 2019, Dr. Prichard served as Humacyte’s Senior Vice President of Product Development following several career progressions leading the Humacyte Research and Development teams.   Dr. Prichard joined the Humacyte organization in 2008 and has been instrumental in leading the process and product development teams for Humacyl through all phases of clinical development.